Developing effective strategies for malaria prevention programs for pregnant African women

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 1 SUPPL., 1996, Pages 95-100

  Steketee, Richard W ^a   Wirima, Jack J ^b   Campbell, Carlos C ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; PLASMODIUM FALCIPARUM;

AFRICA; CONFERENCE PAPER; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MALARIA; MALARIA CONTROL; MATERNAL DISEASE;

AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; CRITIQUE; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; HEALTH; INTEGRATED PROGRAMS; MALARIA--PREVENTION AND CONTROL; MALAWI; ORGANIZATION AND ADMINISTRATION; PARASITE CONTROL; PARASITIC DISEASES; POPULATION; POPULATION CHARACTERISTICS; PREGNANT WOMEN; PROGRAM DEVELOPMENT; PROGRAMS; PUBLIC HEALTH; RISK FACTORS;

AFRICA; ANTIMALARIALS; FEMALE; HEALTH POLICY; HEALTH PROMOTION; HUMANS; MALARIA, FALCIPARUM; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RISK FACTORS;

EID: 0029680586     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.95     Document Type: Article

References (31)

1. Campbell CC, 1991. Challenges facing antimalarial therapy in Africa, J Infect Dis 163: 1207-1211.
2. Nahlen BL, Akintunde A, Alakija T, Nguyen-Dinh P, Ogunbode O, Edungbola LD, Adetoro O, Breman JG, 1989. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet ii: 830-834.
3. Institute of Medicine, 1985. Preventing Low Birth Weight. Washington, DC: National Academy Press.
4. Kramer MS, 1987. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 65: 663-737.
5. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Breman JG, Heymann DL, 1996. Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: the Mangochi Malaria Research Project. Am J Trop Med Hyg 55 (suppl): 8-16.
6. World Health Organization, 1986. WHO expert committee on malaria, 18th report. World Health Organ Tech Rep Ser 735: 57-78.
7. Wolfe MW, Cordero JF, 1985. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J (Clin Res Ed) 290: 1466-1467.
8. Steketee RW, 1989. Recent findings in perinatal malaria. Bull Int Pediatr Assoc 10: 418-433.
9. Kaseje DCO, Sempebwa EKN, Spencer HC, 1987. Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance. Ann Trop Med Parasitai 81: 77-82.
10. Helitzer-Allen DL, Macheso A, Wirima J, Kendall C, 1994. Testing strategies to increase use of chloroquine chemoprophylaxis during pregnancy in Malawi. Acta Trop 58: 255-266.
11. Heymann DL, Steketee RW, Wirima JJ, McFarland DA, Khoromana CO, Campbell CC, 1990. Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost. Trans R Soc Trop Med Hyg 84: 496-498.
12. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG, 1996. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine. Am J Trop Med Hyg 55 (suppl): 24-32.
13. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG, 1996. The effect of malaria and malaria prevention in pregnancy on offspring birth weight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg 55 (suppl): 33-41.
14. McGregor IA, 1984. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 33: 517-525.
15. Brabin BJ, 1991. The Risks and Severity of Malaria in Pregnant Women. Geneva: World Health Organization, Applied Field Research in Malaria Reports. No 1.
16. Steketee RW, Wirima JJ, Slutsker L, Breman JG, Heymann DL, 1996. Comparability of treatment groups and risk factors for parasitemia at first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi. Am J Trop Med Hyg 55 (suppl): 17-23.
17. Steketee RW, Wirima JJ, Bloland PB, Chelima B, Mermin JH, Chitsulo L, Breman JG, 1996. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55 (suppl): 42-49.
18. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG, 1996. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine for malaria. Am J Trop Med Hyg 55 (suppl): 50-56.
19. Schultz LJ, Sleketee RW, Macheso A, Kazemoe P, Ghitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-522.
20. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee RW, Campbell CC, 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
21. Schulz K, Gates W, O'Mara P, 1987. Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. Genitourin Med 63: 320-325.
22. Hinman AR, Foster SO, Wassilak GF, 1987. Neonatal tetanus: potential for elimination in. the world. Pediatr Infect Dis J 6: 813-816.
23. Stanfield JP, Galazka A, 1984. Neonatal tetanus in the world today. Bull World Health Organ 62: 647-669.
24. World Health Organization, 1983. Expanded programme on immunization. Neonatal tetanus mortality survey, Malawi. Wkly Epidemiol Rec 42: 326-327.
25. Berggren GG, Berggren W, Verly A, Gamier N, Perterson W, Ewbank D, Dieudonne W, 1983. Traditional midwives, tetanus immunization, and infant mortality in rural Haiti. Trop Doct 13: 79-87.
26. Rahman S, 1982. The effect of traditional birth attendants and tetanus toxoid in reduction of neonatal mortality. J Trop Pediatr 28: 163-165.
27. Connor EM, Sperling RS, Gelber R, Kiselev P. Scott G, O'Sullivan MJ, Van Dyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy J-F, Culname M, Coomlos R, Elkins M, Moye J, Stratton P Balsley J, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group, 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331: 1173-1180.
28. Schultz LJ, Steketee RW, Chitsulo L, Macheso A, Kazembe P, Wirima JJ, 1996. Evaluation of maternal practices and efficacy of alternative antimalarial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine. Am J Trop Med Hyg 55 (suppl): 87-94.
29. Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatib-N'Jie AB, 1989. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hvg 83: 589-594.
30. Phillips-Howard PA, Steffen R, Kerr L, Van Hauwere B, Schildknecht J, Fuchs E, Edwards R, 1996. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. Bull World Health Organ: (in press).
31. Greenwood AM, Menendez C, Alonso PL, Jaffar S, Langerock P, Lulat S, Todd J, M'Böge B, Francis N, Greenwood BM, 1994. Can malaria chemoprophylaxis be restricted to first pregancies? Trans R Soc Trop Med Hyg 88: 681-682.